Cargando…
Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers
Background: Esophageal squamous cell carcinoma (ESCC) is one of the most fatal diseases worldwide. Because early diagnosis is difficult, ESCC is mostly diagnosed at an advanced stage, leading to a poor overall prognosis. The purpose of this study was to explore the differences between plasma metabol...
Autores principales: | Zhu, Zi-Jia, Qi, Zheng, Zhang, Ji, Xue, Wen-Hua, Li, Li-Feng, Shen, Zhi-Bo, Li, Ze-Yun, Yuan, Yong-Liang, Wang, Wen-Bin, Zhao, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171502/ https://www.ncbi.nlm.nih.gov/pubmed/32328198 http://dx.doi.org/10.7150/jca.41733 |
Ejemplares similares
-
Untargeted metabolomics analysis of esophageal squamous cell cancer progression
por: Yang, Tao, et al.
Publicado: (2022) -
Discovering Hair Biomarkers of Alzheimer’s Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics
por: Su, Yu-Hsiang, et al.
Publicado: (2023) -
Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with esophageal cancer
por: Yang, Xiao-li, et al.
Publicado: (2022) -
Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
por: Yu, Mengjie, et al.
Publicado: (2022) -
Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach
por: Zhang, Yaowen, et al.
Publicado: (2020)